News

Newest mini pacemakers suitable for more than 80 per cent of patients

18 October 2024

Leuven cardiologists have for the first time implanted a new type of mini pacemaker applicable for almost anyone who needs a pacemaker.

UZ Leuven and KU Leuven invest 14 million euros in new cell and gene therapy facility

8 October 2024

UZ Leuven and KU Leuven are establishing an innovative facility for the production of Advanced Therapy Medicinal Products (ATMPs) on the Gasthuisberg Campus. At this facility, they want to develop pioneering therapies themselves from the end of 2025 and produce personalised treatments for individual patients

Successful first edition of Belgian Transplantoux Games in Leuven

26 September 2024

On 21 and 22 September, Transplantoux organised the very first edition of the Belgian Transplantoux Games in Leuven. The sporting event brought together transplant and dialysis patients, donors and sympathisers under the ‘healthy living and excercising after a transplant’ motto. Some 400 sportsmen and women competed for medals in more than 10 disciplines.

New EUHA position paper highlights the role of university hospitals in sustainable care

11 September 2024

This week the European University Hospital Alliance (EUHA) published its position paper 'Rethinking Healthcare Systems'. Among other things, the paper pushes forward three key action points to ensure the future of European healthcare. Discover them here.

Immunotherapy can prevent dangerous blood transfusion in foetus

8 August 2024

A new study shows that the drug nipocalimab is a good alternative for the not harmless blood transfusion in a rhesus pregnancy: the drug ensures that the mother's antibodies can no longer go to the foetus.

Leuven study unravels underlying mechanism of intestinal fibrosis

24 July 2024

Despite advancements in treating chronic inflammation, existing anti-inflammatory medications cannot prevent the development of intestinal fibrosis. Researchers from UZ Leuven and KU Leuven now identified several mechanisms crucial for the development of intestinal fibrosis in a recent study. With this information, they hope to develop potential new treatments.

UZ Leuven largest centre in Belgium for life-saving PEA treatment

17 July 2024

UZ Leuven saccounts for the largest number of pulmonary endarteriectomies in Belgium, with remarkably good survival rates. The cardio-surgeons and pulmonologists involved nurture an ambitious vision for the future: centralise the procedure even more and aim for at least 33 operations a year.

Investment support for UZ Leuven construction projects

6 June 2024

The Flemish government informed the press today that UZ Leuven can count on 14.7 million annual investment support for important infrastructure works. There are new building projects in the pipeline in Leuven that are important for both patients and staff.

New biomarker predicts success of immunotherapy in kidney cancer

21 May 2024

Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team developed a new method to predict which patients will benefit from it. Their study, published in the journal Nature Medicine, also opens new avenues to even more effective treatments.

First results gene therapy for frontotemporal degeneration are promising

14 May 2024

UZ Leuven has been collaborating on an internationl clinical study on gene replacement in FTD with progranulin mutation.

Cancer radiation during pregnancy safe for unborn child

18 April 2024

Cancer radiation during pregnancy is safe for the unborn child, a long-term study from UZ Leuven has shown. The research team brings long-term results of the psychological and physical impact on a child after radiotherapy in the mother during pregnancy for the first time.

New treatment successful for therapy-resistant ovarian cancer

4 April 2024

An international study led by UZ Leuven shows that ovarian cancer patients that are treated with an antibody in combination with chemotherapy survive longer than after a treatment with classic chemotherapy. This finding is a big step in the treatment of ovarian cancer.